Creighton 75, Bradley 58

Tommy Dahlk, The Sports Xchange
The SportsXchange

OMAHA, Neb. -- On a day when nearly everyone at CenturyLink Center Omaha wore pink to raise money for a cancer cure, the man for Creighton who always wears pink, Gregory Echenique, was the one who sparked the Bluejays' 75-58 victory over the Bradley Braves.
Echenique, who always dawns pink shoes, charged Creighton's early run in the second half with two baskets that allowed the Jays to retake the lead, and they never looked back as they notched their 20th win of the season.
Echenique finished with 10 points to complement Doug McDermott, who scored 17 of his 25 points in the second half as Creighton (20-3, 9-2 MVC) flipped a five-point deficit into a blowout in the final nine minutes.
Austin Chatman hit 4 of 7 three-pointers and finished with 16 points for Creighton.
Dyricus Simms-Edwards led Bradley (13-10, 5-6) with 18 points.
Creighton started the first half relatively hot from the field, hitting six three-pointers in the first 10 minutes en route to a 20-13 lead. But the Jays struggled mightily as the half closed.
Bradley's Walt Lemon Jr. scored six straight points, and Bradley ended the first half with a 30-27 lead. The Braves held Creighton to 34.5 percent shooting in the first half, by far one of Creighton's worst shooting halves of the year. The Braves also outrebounded Creighton 20-15.
However, Creighton wasted no time getting back on track and opened the second half on a 6-0 run. Echenique had four points and the Jays forced two turnovers during the run.
Creighton took a 40-36 lead on Chatman's second three-pointer of the half with roughly 15 minutes left that got a once-quiet crowd loud again.
Creighton extended its lead to 61-48 with just over six minutes left on back-to-back baskets by McDermott.
NOTES: Chicago Bulls General Manager John Paxson was at the game scouting. ... 18,111 fans attended the Third-Annual "Creighton Vs. Cancer Third Annual Pink Out." This number was the fourth-largest figure ever at the CenturyLink Center.

What to Read Next